Latest News & Updates
Breaking News
10 minutes ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Tarsus Pharmaceuticals Partners with John Cena to Drive Demodex Blepharitis Diagnosis Rates
Tarsus Pharmaceuticals enlists John Cena to close the diagnostic gap for Demodex blepharitis, affecting an estimated 25 million Americans.
Pharma Now Editorial Team
Oryzon Advances FDA Protocol Resubmission for PORTICO-2 Phase III Trial in BPD Aggression
Oryzon is preparing an FDA protocol resubmission for its PORTICO-2 Phase III vafidemstat trial in BPD aggression, while reporting strong AML data ahead of EHA 2026.
Pharma Now Editorial Team
Grace Sciences' GS-100 AAV9 Therapy Selects Pivotal Dose After Immune-Mediated Events Halt Highest Cohort
Grace Sciences selects 1e15 vg as GS-100 pivotal dose after immune-mediated events halt highest AAV9 cohort in NGLY1 trial.
Pharma Now Editorial Team
Forward Therapeutics Achieves Phase 1 Completion for FT2109, Advancing Oral TNF Inhibitor to Phase 2
Forward Therapeutics completes Phase 1 for oral TNFsi FT2109, advancing to Phase 2 with implications for CMO formulation capacity planning.
Pharma Now Editorial Team
